TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
KRYS

Krystal Biotech Inc

Healthcare · Biotechnology

336.70$ -0.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement KRYS
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0%
13.7% 6.1% 6.9% 7.4%
86.3% 93.9% 93.1% 92.6%
755.7% 91.6% 18.4% 14.9%
404.6% 194.1% 39.1% 37.7%
1,160.3% 310.3% 70.5% 51.2%
-1,160.3% -216.4% 22.6% 41.5%
100.0% 0.0%
-1,060.3% 25.4% 32.8% 48.7%
-2.0% 3.9% 2.1% -3.9%
-1,060.3% 21.6% 30.7% 52.6%
-1,046.5% -180.1% 37.8% 50.4%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?